Plan

SOLVE FSHD is focused on supporting:

• The development, validation and clinical evaluation of biomarkers that predict clinically meaningful outcome measures for use in clinical trials in FSHD.
• Biomarker discovery and Natural History Studies that support drug development efforts.
• Development of pre-clinical systems to increase data quality and success for future therapies advancing to the clinic.
• Development of novel therapies that stop disease progression and/or increase muscle regeneration.

Facilitate developing therapeutics that maintain or improve muscle function, demonstrated by an improvement in muscle strength.

Invest in companies to catalyze a cure through disease modifying treatments.